Laura McLaughlin, MD

Assistant Professor, Pediatrics-Heme/Onc and Bone Marrow Transplantation


FacultyPhoto
Medical School
  • MD, Florida State University College of Medicine (2015)
Undergraduate School
  • BS, University of Florida (FL) (2009)
Residency
  • Baylor College of Medicine Program, Pediatrics (2018)
Fellowships
  • University of Colorado (Children's Hospital Colorado) Program, Pediatric Hematology / Oncology (2021)
  • University of Colorado (Children's Hospital Colorado) Program, Pediatric Bone Marrow Transplantation & Cellular Therapeutics (2022)
Languages
English
Department
Pediatrics-Heme/Onc and Bone Marrow Transplantation

Professional Titles

  • Assistant Professor of Pediatrics

Research Interests

My research interests include the development of novel, less-toxic conditioning regimens and improving transplant outcomes in pediatric patients with non-malignant diseases.

Publications

  • Srinivasan A, McLaughlin L, Wang C, Srivastava DK, Shook DR, Leung W, Hayden RT. Early infections after autologous hematopoietic stem cell transplantation in children and adolescents: the St. Jude experience. Transpl Infect Dis. 2014 Feb;16(1):90-7. PubMed PMID: 24256514
  • Kutzler MA, Cao C, Bai Y, Dong H, Choe PY, Saulino V, McLaughlin L, Whelan A, Choo AY, Weiner DB, Ugen KE. Mapping of immune responses following wild-type and mutant ABeta42 plasmid or peptide vaccination in different mouse haplotypes and HLA Class II transgenic mice. Vaccine. 2006 May 22;24(21):4630-9. PubMed PMID: 16157426
  • Shim SH, Tufa D, Woods R, George TD, Shank T, Yingst A, Lake J, Cobb L, Jones D, Jones K, Verneris MR. SAHA Enhances Differentiation of CD34+CD45+ Hematopoietic Stem and Progenitor Cells from Pluripotent Stem Cells Concomitant with an Increase in Hemogenic Endothelium. Stem Cells Transl Med. 2022 May 27;11(5):513-526. PubMed PMID: 35349707
  • Tufa DM, Yingst AM, Trahan GD, Shank T, Jones D, Shim S, Lake J, Winkler K, Cobb L, Woods R, Jones K, Verneris MR. Human innate lymphoid cell precursors express CD48 that modulates ILC differentiation through 2B4 signaling. Sci Immunol. 2020 Nov 20;5(53). PubMed PMID: 33219153
  • Cobb LM, Verneris MR. Therapeutic manipulation of innate lymphoid cells. JCI Insight. 2021 Mar 22;6(6). PubMed PMID: 33749662
  • McLaughlin L and Knight-Perry J. Graft versus host disease. In: Cabana MD (ed). The 5-Minute Pediatric Consult. 9th ed. Philadelphia, PA: Wolters Kluwer; 2022. In review.
  • McLaughlin L, DeZoeten E, Verneris MR. Can allogeneic haematopoietic cell transplantation be curative in classical Crohn's disease?. Br J Haematol. 2022 Nov 9. [Epub ahead of print] PubMed PMID: 36352551
  • Chen TT, David AP, Gordon SE, McLaughlin L. Ruxolitinib dosing for acute graft-versus-host disease in a pediatric patient receiving continuous renal replacement therapy. Pediatr Blood Cancer. 2023 Oct 30;:e30754. [Epub ahead of print] PubMed PMID: 37899702
  • McLaughlin L, DeZoeten E, Verneris MR. Can allogeneic haematopoietic cell transplantation be curative in classical Crohn's disease?. Br J Haematol. 2023 Mar;200(5):541-542. PubMed PMID: 36352551
  • Chen TT, David AP, Gordon SE, McLaughlin L. Ruxolitinib dosing for acute graft-versus-host disease in a pediatric patient receiving continuous renal replacement therapy. Pediatr Blood Cancer. 2024 Jan;71(1):e30754. PubMed PMID: 37899702

Professional Memberships

  • American Society of Transplantation and Cellular Therapy, Member
  • Alpha Omega Alpha Honor Society, Inductee
  • American Society of Hematology, Member
  • Pediatric Transplantation & Cellular Therapy Consortium, Member
  • Castleman Disease Collaborative Network, Member
  • Histiocytosis Association, Member

Practice Locations

Children's Hospital Colorado Anschutz Medical Campus
13123 East 16th Ave
Aurora, CO 80045
720-777-1234

Hospital Affiliation
  • Children's Hospital Colorado

Specialty Information

Specialties
  • Pediatrics, Board Certification (2018)
  • American Board of Pediatrics, Pediatric Hematology/Oncology, Board Certification (2023)
  • Colorado Medical, License (2018)
  • New Mexico Telemedicine, License (2023)
Conditions & Treatments
  • Cancers - Aplastic Anemia
  • Cancers
  • Cancers - Blood and Marrow Transplant
  • Cancers - Pediatric Cancer
  • Blood / Lymphatic System - Blood Disorders
  • Blood / Lymphatic System
  • Immune System - Autoimmune Disorders
  • Immune System
  • Immune System - Immunodeficiency
Clinical Interests
I specialize in the use of bone marrow transplantation and therapies for children and young adults. I'm primarily interested in treating patients with non-malignant diseases, including immune dysregulation disorders, bone marrow failure syndromes, immunodeficiencies and autoimmune diseases. I'm also interested in other rare diagnoses affecting the immune system, including Castleman disease.

Care Philosophy
I'm committed to providing compassionate, high-quality, patient-centered care as part of a patient's team.

Personal Interests
In my free time, I enjoy hiking, skiing, traveling and spending time with friends, family, my husband and our 2 dogs.

Public Speaking
Yes